Patent · US Active

Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1

US9095552B2 · kind B2 · utility

112Cited by

399References

15Claims

0Family size

Assignee

Moderna Therapeutics, Inc. · US

Inventors

Tirtha Chakraborty · Medford, US
Antonin de Fougerolles · Waterloo, BE

Key dates

Filing date	Dec 12, 2013
Grant date	Aug 4, 2015
Priority date	—
Expiry date	Dec 12, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.